Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.
1234567891011121314151617181920212223
Next »

Drug Approval Trends Don't Extend to CMOs

June 2, 2013
By: Jim Miller
Pharmaceutical Technology

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Outsourcing's Modest Role as a Cost-Containment Strategy

May 2, 2013
By: Eric Langer
Pharmaceutical Technology

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

Strategic Partnering for Manufacturing

April 2, 2013
By: Jim Miller
Pharmaceutical Technology

Eisai and Biogen Idec pursue an innovative approach to capacity management.

Adhering to ICH Q7 for GMPs

March 2, 2013
By: David Elder
Pharmaceutical Technology

FDA's requirements for API manufacturers in regards to ICH Q7.

Navigating the Global Manufacturing Supply Chain

March 2, 2013
By: Patricia Van Arnum
Pharmaceutical Technology

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

End of the Dedicated CMO?

February 2, 2013
By: Jim Miller
Pharmaceutical Technology

Is the contract-only CMO an endangered species?

Seeking Strength in Partnership Strategies

February 1, 2013
By: Patricia Van Arnum
Pharmaceutical Technology

In the arena of pharmaceutical outsourcing, when speaking of partnerships, the discussion typically focuses on the relationship between a pharmaceutical/biopharmaceutical company as the sponsor company and a contract-service provider.

Survey: Optimizing Global Biopharmaceutical Operations Through Risk Mitigation and Management

February 1, 2013
By: Phil Kaminsky, Jiyang Liu, Julia Olsen-Claire
Pharmaceutical Technology

A UC Berkeley survey provides insight into biopharma's risk concerns and strategies.

Building Toolboxes through Cross-Functional Partnerships

February 1, 2013
By: Patricia Van Arnum
Pharmaceutical Technology

When speaking of partnerships, the discussion typically focuses on the relationship between a pharmaceutical/biopharmaceutical company as the sponsor company and a contract-service provider.

1234567891011121314151617181920212223
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here